论文部分内容阅读
目的:评价克林霉素联合庆大霉素对慢性盆腔炎的治疗效果。方法:将2010年11月至2013年4月入院治疗慢性盆腔炎的98例患者随机分为对照组和治疗组各49例,对照组静脉滴注庆大霉素、甲硝唑;治疗组静脉滴注盐酸克林霉素、庆大霉素。结果:治疗组总治愈率97.9%,对照组总治愈率83.6%(P<0.05),具有统计学意义。结论:克林霉素联合庆大霉素对慢性盆腔炎有较好的治疗效果,不良反应少,治愈率高,有临床推广价值。
Objective: To evaluate the effect of clindamycin combined with gentamicin on the treatment of chronic pelvic inflammatory disease. Methods: From November 2010 to April 2013, 98 patients admitted to hospital for treatment of chronic pelvic inflammatory disease were randomly divided into control group and treatment group, with 49 cases in each group. The control group was given gentamicin and metronidazole intravenously. Instillation clindamycin hydrochloride, gentamicin. Results: The total cure rate was 97.9% in the treatment group and 83.6% in the control group (P <0.05), with statistical significance. Conclusion: Clindamycin combined with gentamicin has a better therapeutic effect on chronic pelvic inflammatory disease, less adverse reactions, high cure rate, and clinical promotion value.